During the past decade, Chengdu Second People's Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chengdu Second People's Hospital" #1 sponsor was "Bayer" with 1 trials, followed by "Betta Pharmaceuticals Co., Ltd." with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Cancer Institute and Hospital, Chinese Academy of Medical Sciences" with 1 trials sponsored and "Chengya Chou" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chengdu Second People's Hospital" #1 collaborator was "Bayer" with 1 trials as a collaborator, "Beijing Chao Yang Hospital" with 1 trials as a collaborator, "Biotech Pharmaceutical Co., Ltd." with 1 trials as a collaborator, "China-Japan Friendship Hospital" with 1 trials as a collaborator and "First Affiliated Hospital of Chongqing Medical University" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Chengdu Second People's Hospital" are "Acute Coronary Syndrome" (2 trials), "Acute Aortic Dissection" (1 trials), "Acute Ischemic Stroke" (1 trials), "Acute Myocardial Infarction Type 1" (1 trials) and "Adverse Drug Events" (1 trials). Many other conditions were trialed in "Chengdu Second People's Hospital" in a lesser frequency.

Most popular intervention types in "Chengdu Second People's Hospital" are "Drug" (12 trials), "Radiation" (3 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "docetaxel and cisplatin" (2 trials), "Acarbose" (1 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials) and "Asundexian (BAY2433334)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chengdu Second People's Hospital" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Chengdu Second People's Hospital". 1 are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Chengdu Second People's Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Chengdu Second People's Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".